While the best companies are hard to find, but they can generate massive returns over long periods. To wit, the BioNTech SE ...

This month, Tempus announced a multi-year collaboration with BioNTech SE. Under the collaboration, Tempus is expected to provide analytical support and computational biology expertise to BioNTech ...

Provides updates on BioNTech’s strategy to scale and deploy AI-capabilities across the immunotherapy pipelineHighlights InstaDeep’s new near ...

UBS analyst Eliana Merle maintained a Hold rating on BioNTech SE (BNTX – Research Report) today and set a price target of $131.00. The ...

On Wednesday, TD Cowen maintained its Hold rating on BioNTech (NASDAQ:BNTX), with a consistent price target of $85.00. The firm's stance comes after a detailed review of the company's advancements ...

Google DeepMind by Alphabet Inc. (NASDAQ:GOOGL) (NASDAQ:GOOG) and BioNTech (NASDAQ:BNTX) are collaborating to develop AI lab ...

LONDON, United Kingdom, October 1, 2024 (GLOBE NEWSWIRE)-- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company&CloseCurlyDoubleQuote ...

LONDON - BioNTech SE (NASDAQ:BNTX), in collaboration with its AI subsidiary InstaDeep Ltd., has presented an update on its artificial intelligence (AI) strategies during its Innovation Series ...

Provides updates on BioNTech’s strategy to scale and deploy AI-capabilities across the immunotherapy pipeline Highlights InstaDeep’s new near exascale supercomputer, Kyber, with the aim of ...

On Wednesday, TD Cowen maintained its Hold rating on BioNTech (NASDAQ:BNTX), with a consistent price target of $85.00. The firm's stance comes after a detailed review of the company's advancements in ...